Investing 3 ETF picks that could deliver strong upside in July’s rally by July 2, 2026 July 2, 2026 Wall Street is heading into July with a more bullish tone after a volatile June,… 0 FacebookTwitterPinterestEmail
Investing SoftBank stock surges: is OpenAI loan the next big AI catalyst? by July 2, 2026 July 2, 2026 SoftBank Group stock rose on Thursday after a report said the Japanese investor had revived… 0 FacebookTwitterPinterestEmail
Investing Nikkei 225 Index outlook for July: Top 4 catalysts to watch this month by July 2, 2026 July 2, 2026 The Nikkei 225 Index has sold off recently as investors book profits following its strong… 0 FacebookTwitterPinterestEmail
Investing Here’s why Samsung, SK Hynix, and Kioxia stocks are diving today by July 2, 2026 July 2, 2026 Top Asian stocks in the memory industry retreated sharply today, July 2, as profit-taking gained… 0 FacebookTwitterPinterestEmail
Investing Here’s why the Kospi Index is slumping today (July 2) by July 2, 2026 July 2, 2026 The Kospi Index slumped by over 7% as volatility in the South Korea’s equity market… 0 FacebookTwitterPinterestEmail
Investing Robinhood stock jumps on AI crypto tools and global expansion plans by July 1, 2026 July 1, 2026 Robinhood HOOD shares surged 8% on Wednesday after the online brokerage unveiled a series of… 0 FacebookTwitterPinterestEmail
Investing Dow hits record high before fading as chip selloff weighs on Nasdaq by July 1, 2026 July 1, 2026 The Dow Jones Industrial Average touched a fresh intraday record on Wednesday before giving up… 0 FacebookTwitterPinterestEmail
Investing Why is Microsoft stock gaining 4% today? by July 1, 2026 July 1, 2026 Microsoft MSFT shares rose 4% on Wednesday after consumer health company Haleon announced a new… 0 FacebookTwitterPinterestEmail
Investing Why Paul Pelosi, Jim Cramer prefer Intel stock over AMD by July 1, 2026 July 1, 2026 The race for semiconductor supremacy has taken an unexpected turn. High-profile names are now increasingly… 0 FacebookTwitterPinterestEmail
Investing Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review by July 1, 2026 July 1, 2026 Hims & Hers Health shares (HIMS) surged 9% on Wednesday after Canaccord Genuity raised its… 0 FacebookTwitterPinterestEmail